XML 15 R22.htm IDEA: XBRL DOCUMENT v3.19.3
Employee Equity Incentive Plans
 6 Months Ended
Oct. 04, 2019
Share-based Payment Arrangement [Abstract]  
Employee Equity Incentive Plans Employee Equity Incentive Plans
The following table sets forth the stock-based compensation expense recognized for our equity incentive plans:
 
Three Months Ended
 
Six Months Ended
(In millions)
October 4, 2019
 
September 28, 2018
 
October 4, 2019
 
September 28, 2018
Cost of revenues
$
1

 
$
1

 
$
1

 
$
3

Sales and marketing
6

 
11

 
13

 
22

Research and development
8

 
8

 
15

 
16

General and administrative
14

 
18

 
26

 
47

Total stock-based compensation from continuing operations
29

 
38

 
55

 
88

Discontinued operations
41

 
59

 
95

 
122

Total stock-based compensation expense
$
70

 
$
97

 
$
150

 
$
210

Income tax benefit for stock-based compensation expense
$
(14
)
 
$
(21
)
 
$
(29
)
 
$
(47
)

The following table summarizes additional information related to our stock-based awards, including awards associated with our discontinued operations:
 
Six Months Ended
(In millions, except per grant data)
October 4, 2019
 
September 28, 2018
Restricted stock units (RSUs):
 
 
 
Weighted-average fair value per award granted
$
19.50

 
$
21.65

Awards granted
12

 
12

Total fair value of awards released
$
199

 
$
195

Outstanding and unvested
20

 
21

Performance-based restricted stock units (PRUs):
 
 
 
Weighted-average fair value per award granted
$
19.21

 
$
21.23

Awards granted
2

 
2

Total fair value of awards released
$
28

 
$
8

Outstanding and unvested at target payout
3

 
5

Stock options:
 
 
 
Weight-average fair value per award granted
$
4.76

 
$
—

Awards granted
2

 
—

Total intrinsic value of stock options exercised
$
113

 
$
11

Outstanding
6

 
13

Exercisable
4

 
12

Restricted stock:
 
 
 
Outstanding and unvested
—

 
1


For certain employees, we settled fiscal 2019 bonuses in approximately 1 million RSUs. These awards were granted and vested in the first quarter of fiscal 2020. As of October 4, 2019 and March 29, 2019, the total liability associated with liability-classified awards was $6 million and $22 million, respectively, which is presented in Accrued compensation and benefits in our Condensed Consolidated Balance Sheets.
As of October 4, 2019, the total unrecognized stock-based compensation costs related to our unvested stock-based awards was $446 million, which will be recognized over an estimated weighted-average amortization period of 1.9 years.